Gentamicin pharmacokinetics during hemodialysis. Previous research has permitted the development of a method for the estimation of gentamicin dosage requirement for varying degrees of renal insufficiency. In the present study we have undertaken precise measurement of the Kiil hemodialyzer clearance of gentamicin and have extended earlier kinetic models to facilitate gentamicin administration to dialysis patients. Due to the dialysis characteristics of gentamicin, the results can be extrapolated to gentamicin administration when other hemodialyzers are employed. Our findings also demonstrate the significance of residual renal function in dialysis patients in the determination of gentamicin dosage requirements.Pharmacocinétique de la gentamyc...
Background\ud The purpose of this study was to evaluate the feasibility of utilizing an in-vitro, cl...
Gentamicin has been given to patients with compromised renal function or severe renal failure, in to...
Gentamicin remains one of the primary antibiotics used for treatment of gram-negative infections des...
Background and Objectives: Aminoglycoside antibiotics are commonly used in chronic kidney disease st...
The aim of this study was to ascertain the most suitable dosing schedule for gentamicin in patients ...
Gentamicin pharmacokinetics during slow daily home hemodialysis.BackgroundGentamicin is commonly use...
The effects of four types of artificial kidney on dialyzer clearance rates and serum pharmacokinetic...
Pharmacokinetics of gentamicin during peritoneal dialysis in children. The pharmacokinetics of genta...
BACKGROUND/AIMS: Gentamicin pharmacokinetics have not been described in patients undergoing short-da...
The aim of this study was to describe the safety profile and pharmacokinetic/pharmacodynamic paramet...
The objective of the present prospective pharmacokinetic study was to describe the variability of pl...
Gentamicin pharmacokinetics during slow daily home hemodialysis.BackgroundGentamicin is commonly use...
Introduction: Dosage Optimization of gentamicin in hemodialysis is essential to ensure its antibacte...
Pharmacokinetics of gentamicin in the treatment of renal infection: A therapeutic anomaly explained....
When treating critically ill patients with gentamicin for severe infection, peak concentrations (C-m...
Background\ud The purpose of this study was to evaluate the feasibility of utilizing an in-vitro, cl...
Gentamicin has been given to patients with compromised renal function or severe renal failure, in to...
Gentamicin remains one of the primary antibiotics used for treatment of gram-negative infections des...
Background and Objectives: Aminoglycoside antibiotics are commonly used in chronic kidney disease st...
The aim of this study was to ascertain the most suitable dosing schedule for gentamicin in patients ...
Gentamicin pharmacokinetics during slow daily home hemodialysis.BackgroundGentamicin is commonly use...
The effects of four types of artificial kidney on dialyzer clearance rates and serum pharmacokinetic...
Pharmacokinetics of gentamicin during peritoneal dialysis in children. The pharmacokinetics of genta...
BACKGROUND/AIMS: Gentamicin pharmacokinetics have not been described in patients undergoing short-da...
The aim of this study was to describe the safety profile and pharmacokinetic/pharmacodynamic paramet...
The objective of the present prospective pharmacokinetic study was to describe the variability of pl...
Gentamicin pharmacokinetics during slow daily home hemodialysis.BackgroundGentamicin is commonly use...
Introduction: Dosage Optimization of gentamicin in hemodialysis is essential to ensure its antibacte...
Pharmacokinetics of gentamicin in the treatment of renal infection: A therapeutic anomaly explained....
When treating critically ill patients with gentamicin for severe infection, peak concentrations (C-m...
Background\ud The purpose of this study was to evaluate the feasibility of utilizing an in-vitro, cl...
Gentamicin has been given to patients with compromised renal function or severe renal failure, in to...
Gentamicin remains one of the primary antibiotics used for treatment of gram-negative infections des...